Recessive hereditary methaemoglobinaemia, type II: delineation of the clinical spectrum

Brain : a Journal of Neurology
C EwenczykE Roze

Abstract

Type II recessive hereditary methaemoglobinaemia (RHM) is a rare disease due to generalized NADH-cytochrome b5 reductase (cytb5r) deficiency. It results in mild cyanosis and severe neurological impairment. The clinical features and long-term outcome are poorly documented, and there are no systematic reviews. We examined six cases of type II RHM, four of which were new, together with 45 previously published cases, in order to establish the range of phenotypic expression. The clinical picture was very similar in most cases, with severe encephalopathy, microcephaly, generalized dystonia, movement disorders and mild cyanosis. The neurological prognosis was poor; in particular, none of the patients walked or spoke. In addition, the possibility of an atypical and milder phenotype was considered. We concluded that children with unexplained severe encephalopathy associated with generalized dystonia should be examined for cyanosis and have a methaemoglobinaemia assay performed. The diagnosis can be confirmed by very low cytb5r activity in both red and white blood cells. Here we report three novel mutations in the NADH-cytochrome b5 reductase gene. Prenatal diagnosis of this extremely severe disease should be proposed to affected families.

Citations

Jun 20, 2008·Journal of Inherited Metabolic Disease·F SedelM Vidailhet
Apr 16, 2010·Journal of the American Chemical Society·Judith M NocekBrian M Hoffman
Feb 23, 2013·Applied Neuropsychology. Child·Leonard F Koziol, Michael C Stevens
May 26, 2012·Journal of Pediatric Hematology/oncology·Melanie J PercyTerence R Lappin
Feb 8, 2014·Cornea·Sunita ChaurasiaArchana Bhargava
Jan 24, 2014·Antioxidants & Redox Signaling·Emilio SiendonesPlácido Navas
Nov 2, 2012·Critical Reviews in Biotechnology·Fatemeh ElahianSeyed Abbas Mirzaei
Nov 18, 2015·Pediatric Blood & Cancer·Monica S CooperChris Barnes
Feb 18, 2016·Case Reports in Obstetrics and Gynecology·S VermaG Gandhi
Feb 26, 2011·Blood Cells, Molecules & Diseases·Felipe R LorenzoJosef T Prchal
Nov 23, 2010·Revue neurologique·D GrabliE Roze
Jul 24, 2010·Brain & Development·Carlo FuscoPaola Bianchi
Jan 15, 2014·Journal of Child Neurology·Kalpana DevadathanP A Mohammed Kunju
May 28, 2009·Journal of Child Neurology·Michelle P HudspethKenton R Holden
Jun 7, 2017·Circulation Research·Mizanur M RahamanAdam C Straub
Apr 3, 2019·BMJ Case Reports·Amal Paul, Sujith Thomas Chacko
Oct 13, 2018·Journal of Clinical Medicine·Emilio SiendonesPlácido Navas
Jan 30, 2018·Clinical Case Reports·Elizabeth A ManninoSamantha A Schrier Vergano
Oct 28, 2019·Journal of Veterinary Internal Medicine·Jared A JaffeyUNKNOWN 99 Lives Cat Genome Consortium
Nov 23, 2019·Clinics and Practice·Ernestas ViršilasArūnas Liubšys
Mar 16, 2021·International Journal of Pediatrics & Adolescent Medicine·Haya S AlFarisMohammad A Al-Muhaizea
Sep 2, 2021·American Journal of Hematology·Achille IolasconUNKNOWN SWG of red cell and iron of EHA and EuroBloodNet

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.